2021, Number 1
Soft tissue myxofibrosarcoma: a case report
Language: Spanish
References: 12
Page: 121-127
PDF size: 437.75 Kb.
ABSTRACT
Background: soft tissue sarcomas are frequent lesions today and can affect a large num-ber of patients at any age, their histological types are very varied hence the clinical behavior of these entities.Objective: to present a patient with myxofibrosarcoma in the anterior region of the right knee.
Case report: 56-year-old white woman with a history of essential arterial hypertension, who goes to the outpatient department of Orthopedics and Traumatology for referring to having a tumor in the anterior part of the right knee that is accompanied by slight pain and functional disability. It appeared two years ago, but it has increased its size rapidly in the last three months. Taking into account all the previous elements, it was decided to take the patient to the operating room, for sur-gical treatment, where the tumor described above was removed surgically through the surrounding healthy tissue with safety margin, the piece was sent to the department of pathological anatomy for histological study, which later reported a tumor of myxofibrosarcoma type.
Conclusions: myxofibrosarcoma is a malignant lesion that is located in the lower limb, of slow growth with absence of little pain, the imaging means provide very important information for its diagnosis, specifically high resolution ultrasound and magnetic resonance imaging. Timely surgical treatment through extensive resection improves the prognosis.
REFERENCES
Callegaro D, Miceli R, Bonvalot S, Ferguson P, Strauss DC, Levy A, et al. Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres. Eur J Cancer [Internet]. 2018 Dec [citado 20 Ene 2020];105:19-27. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0959804918313984?via%3Dihub
Widemann BC, Italiano A. Biology and management of undifferentiated pleomorphic sarcoma, myxofibrosarcoma, and malignant peripheral nerve sheath tumors: state of the art and perspectives. J Clin Oncol [Internet]. 2018 [citado 20 Ene 2020];36(2):160-7. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759316/.
Hu Q, Zhou S, Hu X, Zhang H, Huang S, Wang Y. Systematic screening identifies a 2-gene signa-ture as a high-potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcoma. J Cell Mol Med [Internet]. 2020 [citado 20 Ene 2020];24(1):1010-21. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933343/. doi: 10.1111/jcmm.14814.
Kikuta K, Nakayama R, Yamaguchi S, Nishiwaki Y, Susa M, Nishimoto K, et al. Wide-spread ignorance on the treatment of subcutaneous malignant tumors; a questionnaire-based study. Jpn J Clin Oncol [Internet]. 2018 Feb [citado 20 Ene 2020];48(2):130-4. Disponible en: https://academic.oup.com/jjco/article/48/2/130/4774981 doi: 10.1093/jjco/hyx184